Table 2.
Baseline patient characteristics
| Characteristic | Median [range] or No. (%) |
|---|---|
| Age, years |
72 [17–85] |
| Male gender |
28 (61) |
| ECOG status |
|
| 0 |
16 (35) |
| 1 |
23 (50) |
| 2 |
6 (13) |
| Unknown |
1 (2) |
| Time since diagnosis, years |
2.9 [0–21] |
| Number of prior systemic therapies |
3 [1-9] |
| Prior ASCT |
16 (35) |
| Diagnosis after confirmatory review |
|
| DLBCL |
40 (87) |
| Follicular NHL (grade 2) |
3 (7) |
| Marginal zone |
2 (4) |
| Diffuse large cell NHL, lineage undetermined |
1 (2) |
| DLBCL subtype |
|
| GCB |
14 (30) |
| Non-GCB |
14 (30) |
| Missing |
18 (39) |
| CD40 staining intensity |
|
| 0 |
1 (2) |
| 1+ |
2 (4) |
| 2+ |
13 (28) |
| 3+ |
25 (54) |
| Not available | 5 (11) |
ECOG, Eastern Cooperative Oncology Group; ASCT, autologous stem cell transplantation; DLBCL, diffuse large B-cell lymphoma; GCB, germinal center B-cell; NHL, non-Hodgkin lymphoma.